Propranolol and etodolac: Clinical Trials

3 trials of Propranolol and etodolac, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 unknown, 1 recruiting. 2 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 22Recruiting 1, Unknown 1
Phase 31Unknown 1

Follow Propranolol and etodolac: new trials by email Literature Review of Propranolol and etodolac trials Research Report on Propranolol and etodolac

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Perioperative Intervention to Reduce Metastatic Processes in Pancreatic Cancer Patients Undergoing Curative Surgery
Propranolol and etodolac, Placebo - Pancreatic Neoplasms
Phase 2UnknownAssaf-Harofeh Medical Center2102019-11-202019-11-20
Colorectal Metastasis Prevention International Trial 2
Propranolol and etodolac, Placebo - Colorectal Neoplasms
Phase 2RecruitingAssaf-Harofeh Medical Center2002019-02-282019-04-18
β-adrenergic Blocker and a COX2 Inhibitor for Prevention of Colorectal Cancer Recurrence
Propranolol and Etodolac - Colorectal Neoplasms
Phase 3UnknownSheba Medical Center4002010-01-012011-07-12

Conditions studied

Colorectal Neoplasms (2)  ·  Pancreatic Neoplasms (1)

Sponsors

Assaf-Harofeh Medical Center (2)  ·  Sheba Medical Center (1)

Countries

Israel (3)

Top investigators

Oded Zmora, MD (2)

Results publications

PMID 42088573, PMID 24050955, PMID 28490464, PMID 29800703